STOCK TITAN

Dennis Polk trades TD SYNNEX (NYSE: SNX) options and sells shares

Filing Impact
(Very High)
Filing Sentiment
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

TD SYNNEX insider Dennis Polk reported multiple stock option exercises and related share sales. On January 12, 2026, Polk exercised stock options to acquire 3,997 common shares at $106.35 per share and employee stock options to acquire 15,372 and 631 common shares at $107.32 per share. The options vest 20% after one year from grant and then monthly in 1/60th increments.

On the same date, he sold blocks of common stock, including 7,432 shares at a weighted average price of $149.61, 631 shares at $149.67, and 11,937 shares at a weighted average price of $150.23, with detailed price breakdowns available on request. After these transactions, Polk directly held 34,099 TD SYNNEX common shares and indirectly held 72,807 shares through a trust.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
POLK DENNIS

(Last) (First) (Middle)
44201 NOBEL DRIVE

(Street)
FREMONT CA 94538

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
TD SYNNEX CORP [ SNX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Hyve Solutions Executive
3. Date of Earliest Transaction (Month/Day/Year)
01/12/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 01/12/2026 M 3,997 A $106.35 38,096 D
Common Stock 01/12/2026 M 15,372 A $107.32 53,468 D
Common Stock 01/12/2026 M 631 A $107.32 54,099 D
Common Stock 01/12/2026 S 7,432 D $149.61(1) 46,667 D
Common Stock 01/12/2026 S 631 D $149.67 46,036 D
Common Stock 01/12/2026 S 11,937 D $150.23(2) 34,099 D
Common Stock 72,807 I By Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $106.35 01/12/2026 M 3,997 (3) 01/19/2032 Common Stock 3,997 $0 1,985 D
Employee Stock Option (Right to Buy) $107.32 01/12/2026 M 15,372 (3) 10/05/2031 Common Stock 15,372 $0 28,212 D
Employee Stock Option (Right to Buy) $107.32 01/12/2026 M 631 (3) 10/05/2031 Common Stock 631 $0 27,581 D
Explanation of Responses:
1. Represents the weighted average sales price for a number of transactions effected at prices ranging from $149.38 to $149.95. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.
2. Represents the weighted average sales price for a number of transactions effected at prices ranging from $150.01 to $150.51. The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.
3. This stock option vests as to 20% of the shares on the first anniversary of the date of grant and vests as to 1/60th of the shares monthly thereafter.
Remarks:
/s/ Cheryl Grant, attorney-in-fact 01/13/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who is the insider trading TD SYNNEX (SNX) stock on this Form 4?

The reporting person is Dennis Polk, a director and Hyve Solutions Executive of TD SYNNEX.

What stock options did Dennis Polk exercise in TD SYNNEX (SNX)?

On January 12, 2026, Dennis Polk exercised options to acquire 3,997 shares at $106.35 and employee stock options for 15,372 and 631 shares at $107.32 per share.

At what prices did Dennis Polk sell TD SYNNEX (SNX) shares?

He sold 7,432 shares at a weighted average of $149.61, 631 shares at $149.67, and 11,937 shares at a weighted average of $150.23, with detailed price ranges noted in the footnotes.

How many TD SYNNEX (SNX) shares does Dennis Polk hold after these transactions?

Following the reported transactions, Dennis Polk directly owned 34,099 common shares and indirectly owned 72,807 shares through a trust.

What does the vesting schedule for Dennis Polk’s TD SYNNEX options look like?

The Form 4 states that the stock option vests as to 20% of the shares on the first anniversary of the grant date and then as to 1/60th of the shares monthly thereafter.

How are the weighted average sale prices on the TD SYNNEX (SNX) Form 4 explained?

The filing notes that the weighted average prices of $149.61 and $150.23 represent multiple trades within stated price ranges, and that detailed share counts at each price are available upon request from the issuer, the SEC staff, or any security holder.
TD SYNNEX CORPORATION

NYSE:SNX

SNX Rankings

SNX Latest News

SNX Latest SEC Filings

SNX Stock Data

12.50B
75.98M
6.54%
93.53%
3.14%
Electronics & Computer Distribution
Wholesale-computers & Peripheral Equipment & Software
Link
United States
FREMONT